Your browser doesn't support javascript.
loading
The PanCareFollowUp Care Intervention: A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer.
van Kalsbeek, Rebecca J; Mulder, Renée L; Haupt, Riccardo; Muraca, Monica; Hjorth, Lars; Follin, Cecilia; Kepak, Tomas; Kepakova, Katerina; Uyttebroeck, Anne; Mangelschots, Marlies; Winther, Jeanette Falck; Loonen, Jacqueline J; Michel, Gisela; Bardi, Edit; Elmerdahl Frederiksen, Line; den Hartogh, Jaap; Mader, Luzius; Roser, Katharina; Schneider, Carina; Brown, Morven C; Brunhofer, Melanie; Göttgens, Irene; Hermens, Rosella P M G; Kienesberger, Anita; Korevaar, Joke C; Skinner, Roderick; van der Pal, Helena J H; Kremer, Leontine C M.
Afiliação
  • van Kalsbeek RJ; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Mulder RL; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Haupt R; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Muraca M; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Hjorth L; Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Paediatrics, Lund, Sweden.
  • Follin C; Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Oncology, Lund, Sweden.
  • Kepak T; International Clinical Research Centre (FNUSA-ICRC), St. Anne's University Hospital, Masaryk University, Brno, Czech Republic.
  • Kepakova K; International Clinical Research Centre (FNUSA-ICRC), St. Anne's University Hospital, Masaryk University, Brno, Czech Republic.
  • Uyttebroeck A; Department of Oncology, Paediatric Oncology, KU Leuven, Department of Paediatric Haematology and Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Mangelschots M; Department of Oncology, Paediatric Oncology, KU Leuven, Department of Paediatric Haematology and Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Winther JF; Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.
  • Loonen JJ; Department of Haematology, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Michel G; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
  • Bardi E; PanCare, Bussum, the Netherlands; St Anna Children's Hospital, Vienna, Austria; Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria.
  • Elmerdahl Frederiksen L; Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark.
  • den Hartogh J; PanCare, Bussum, the Netherlands; Childhood Cancer International Europe, Vienna, Austria.
  • Mader L; Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Roser K; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
  • Schneider C; Childhood Cancer International Europe, Vienna, Austria.
  • Brown MC; Population Health Sciences Institute, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom; Newcastle University Centre for Cancer, Wolfson Childhood Cancer Research Centre, Herschel Building, Newcastle Upon Tyne, United Kingdom.
  • Brunhofer M; Childhood Cancer International Europe, Vienna, Austria.
  • Göttgens I; Department of Primary and Community Care, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Hermens RPMG; Radboud University Medical Centre, Radboud Institute for Health Sciences, Scientific Institute for Quality of Healthcare (IQ Healthcare), Nijmegen, the Netherlands.
  • Kienesberger A; Childhood Cancer International Europe, Vienna, Austria.
  • Korevaar JC; Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
  • Skinner R; Newcastle University Centre for Cancer, Wolfson Childhood Cancer Research Centre, Herschel Building, Newcastle Upon Tyne, United Kingdom; Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom; Translational and Clinical Research Institute, Wolfson Childhood C
  • van der Pal HJH; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands; PanCare, Bussum, the Netherlands. Electronic address: H.J.H.vanderPal@prinsesmaximacentrum.nl.
  • Kremer LCM; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands; Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands; Faculty of Medicine, Utrecht University and Utrecht Medical Centre, Utrecht, the Netherlands.
Eur J Cancer ; 162: 34-44, 2022 02.
Article em En | MEDLINE | ID: mdl-34953441
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article